Relevant bibliographies by topics / Pulmonary surfactant

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers
  6. Reports

Academic literature on the topic 'Pulmonary surfactant'

Author: Grafiati
Published: 4 June 2021
Last updated: 25 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Pulmonary surfactant.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Pulmonary surfactant"

1

van Golde, LMG, JJ Batenburg, and B. Robertson. "The Pulmonary Surfactant System." Physiology 9, no. 1 (1994): 13–20. http://dx.doi.org/10.1152/physiologyonline.1994.9.1.13.

Full text
Abstract:
The pulmonary surfactant system includes specific proteins involved in the regulation of surfactant secretion and recycling, conversion of secreted lamellar bodies to tubular myelin, film adsorption, and stimulation of alveolar macrophages. Hydrophobic proteins are essential for the rapid physiological action of exogenous surfactants currently used in clinical practice.
APA, Harvard, Vancouver, ISO, and other styles
2

Ramanathan, Rangasamy. "Surfactants in the Management of Respiratory Distress Syndrome in Extremely Premature Infants." Journal of Pediatric Pharmacology and Therapeutics 11, no. 3 (2006): 132–44. http://dx.doi.org/10.5863/1551-6776-11.3.132.

Full text
Abstract:
Respiratory distress syndrome (RDS) is primarily due to decreased production of pulmonary surfactant, and it is associated with significant neonatal morbidity and mortality. Exogenous pulmonary surfactant therapy is currently the treatment of choice for RDS, as it demonstrates the best clinical and economic outcomes. Studies confirm the benefits of surfactant therapy to include reductions in mortality, pneumothorax, and pulmonary interstitial emphysema, as well as improvements in oxygenation and an increased rate of survival without bronchopulmonary dysplasia. Phospholipids (PL) and surfactant
APA, Harvard, Vancouver, ISO, and other styles
3

Dipak, Kumar Dhar, and Paul Debasish. "Surfactant Replacement Therapy: An Overview." International Journal of Science and Healthcare Research 5, no. 2 (2020): 399–406. https://doi.org/10.5281/zenodo.3931623.

Full text
Abstract:
Pulmonary surfactant is a soap-like chemical synthesized by type II alveolar pneumocytes and is a mixture of phospholipids (predominantly dipalmitoylphosphatidylcholine), some other lipids and proteins. Its main functions include lowering the surface tension and maintaining the stability of alveoli. The first documented trial involving exogenous use of surfactants as a therapy was recorded in early 1970s using synthetically produced phospholipid mixtures once the chemical composition of surfactants was deciphered. Gradually there was a transition to the use of more natural sources. And animal
APA, Harvard, Vancouver, ISO, and other styles
4

Satyam Prakash, Hem Shankar Yadav, and Om Prakash Yadav. "Pulmonary Surfactant in Health and Disease: An Overview." Janaki Medical College Journal of Medical Science 12, no. 03 (2024): 108–22. https://doi.org/10.3126/jmcjms.v12i03.73990.

Full text
Abstract:
Surfactant is a complex mixture of phospholipids, mainly dipalmitoylphosphatidylcholine (DPCC) and surfactant proteins (SP); SP-A, SP-B, SP-C, and SP-D. DPCC plays a crucial role in lowering the surface tension, while SPs provide immunity against invading pathogens. SPs also enhance the activity of phospholipids, aiding in the adsorption and spread of surfactants all over the alveolar surface. Surfactant production starts as early as 24 weeks of gestation in humans and peaks at about 36-38 weeks. The generation and secretion of lung surfactants are tightly regulated processes. Surfactant is sy
APA, Harvard, Vancouver, ISO, and other styles
5

Ignatova, G. L., V. N. Antonov, and I. A. Zakharova. "The use of exogenous surfactant in pulmonological practice." Meditsinskiy sovet = Medical Council, no. 5 (May 9, 2024): 41–48. http://dx.doi.org/10.21518/ms2024-089.

Full text
Abstract:
A lung surfactant is a complex mixture of lipids and proteins necessary to maintain proper lung function. Drug changes play an important role in chronic lung diseases such as chronic obstructive pulmonary disease, bronchial asthma and idiopathic pulmonary fibrosis. The purpose of this article is to substantiate the use of exogenous surfactant in various respiratory diseases, based on the analysis of publications in domestic and international medical journals, as well as their own experience of application in real clinical practice. This review primarily discusses the contribution of pulmonary
APA, Harvard, Vancouver, ISO, and other styles
6

Bernhard, Wolfgang, Andreas Gebert, Gertrud Vieten, et al. "Pulmonary surfactant in birds: coping with surface tension in a tubular lung." American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 281, no. 1 (2001): R327—R337. http://dx.doi.org/10.1152/ajpregu.2001.281.1.r327.

Full text
Abstract:
As birds have tubular lungs that do not contain alveoli, avian surfactant predominantly functions to maintain airflow in tubes rather than to prevent alveolar collapse. Consequently, we have evaluated structural, biochemical, and functional parameters of avian surfactant as a model for airway surfactant in the mammalian lung. Surfactant was isolated from duck, chicken, and pig lung lavage fluid by differential centrifugation. Electron microscopy revealed a uniform surfactant layer within the air capillaries of the bird lungs, and there was no tubular myelin in purified avian surfactants. Phosp
APA, Harvard, Vancouver, ISO, and other styles
7

Suresh, G. K., and R. F. Soll. "Exogenous Surfactant Therapy in Newborn Infants." Annals of the Academy of Medicine, Singapore 32, no. 3 (2003): 335–45. http://dx.doi.org/10.47102/annals-acadmedsg.v32n3p335.

Full text
Abstract:
Exogenous surfactant therapy has an established role in the management of neonatal respiratory distress syndrome (RDS). This article summarises the current evidence on surfactant therapy. The use of surfactant for the treatment or prophylaxis of neonatal RDS results in a 30% to 65% relative reduction in the risk of pneumothorax and up to a 40% relative reduction in the risk of mortality. Adverse effects, of which pulmonary haemorrhage is of most concern, are infrequent and long-term follow-up studies of treated patients are reassuring. Natural surfactants have advantages over synthetic surfact
APA, Harvard, Vancouver, ISO, and other styles
8

PUTMAN, Esther, Lambert A. J. M. CREUWELS, Lambert M. G. van GOLDE, and Henk P. HAAGSMAN. "Surface properties, morphology and protein composition of pulmonary surfactant subtypes." Biochemical Journal 320, no. 2 (1996): 599–605. http://dx.doi.org/10.1042/bj3200599.

Full text
Abstract:
Separation of surfactant subtypes is now commonly used as a parameter in assessing the amount of active compared with inactive material in various models of lung injury. The protein content, morphology and surface activity were determined of the heavy and light subtype isolated by differential centrifugation. Here we report the presence of surfactant proteins B and C in the heavy subtype but not in the light subtype. Adsorption studies revealed that separation of fast adsorbing bronchoalveolar lavage resulted in slowly adsorbing heavy and light subtypes. Surfactant, reconstituted from heavy an
APA, Harvard, Vancouver, ISO, and other styles
9

Dushianthan, Ahilanandan, Michael P. W. Grocott, Ganapathy Senthil Murugan, Tom M. A. Wilkinson, and Anthony D. Postle. "Pulmonary Surfactant in Adult ARDS: Current Perspectives and Future Directions." Diagnostics 13, no. 18 (2023): 2964. http://dx.doi.org/10.3390/diagnostics13182964.

Full text
Abstract:
Acute respiratory distress syndrome (ARDS) is a major cause of hypoxemic respiratory failure in adults, leading to the requirement for mechanical ventilation and poorer outcomes. Dysregulated surfactant metabolism and function are characteristic of ARDS. A combination of alveolar epithelial damage leading to altered surfactant synthesis, secretion, and breakdown with increased functional inhibition from overt alveolar inflammation contributes to the clinical features of poor alveolar compliance and alveolar collapse. Quantitative and qualitative alterations in the bronchoalveolar lavage and tr
APA, Harvard, Vancouver, ISO, and other styles
10

Nguyen, Thuy N., Stephanie M. Cunsolo, Peter Gal, and J. Laurence Ransom. "Infasurf and Curosurf: Theoretical and Practical Considerations with New Surfactants." Journal of Pediatric Pharmacology and Therapeutics 8, no. 2 (2003): 97–114. http://dx.doi.org/10.5863/1551-6776-8.2.97.

Full text
Abstract:
Type II pneumocytes, normally responsible for surfactant production and release, are insufficiently formed and differentiated in the premature infant born before 34 weeks' gestation. Without an adequate amount of pulmonary surfactant, alveolar surface tension increases, leading to collapse and decreased lung compliance. Pulmonary surfactants are naturally occurring substances made of lipids and proteins. They lower surface tension at the interface between the air in the lungs, specifically at the alveoli, and the blood in the capillaries. This review examines the relative benefits of the two m
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Pulmonary surfactant"

1

Lewis, R. W. "Pulmonary surfactant metabolism." Thesis, Cardiff University, 1985. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.332108.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Hockey, Peter Morey. "Pulmonary surfactant and asthma." Thesis, University of Southampton, 2000. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.274434.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Nilsson, Kristina. "Solute exchange across the alveolo-capillary barrier." Lund : Depts. of Clinical Physiology, Malmö University Hospital and Lund University Hospital, Lund University, 1997. http://books.google.com/books?id=A0hrAAAAMAAJ.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Mo, Young Keun. "Surfactant proteins in extra pulmonary sites /." [St. Lucia, Qld.], 2005. http://www.library.uq.edu.au/pdfserve.php?image=thesisabs/absthe19083.pdf.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Sullivan, Lucy Catherine. "The molecular evolution of vertebrate pulmonary surfactant /." Title page, summary and introduction only, 1996. http://web4.library.adelaide.edu.au/theses/09SB/09sbs949.pdf.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Worthman, Lynn-Ann D. "Surfactant protein A (SP-A) affects pulmonary surfactant morphology and biophysical properties." Thesis, National Library of Canada = Bibliothèque nationale du Canada, 1997. http://www.collectionscanada.ca/obj/s4/f2/dsk2/tape16/PQDD_0014/MQ34241.pdf.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Wood, Philip. "Control of pulmonary surfactant secretion : an evolutionary perspective /." Title page, table of contents and abstract only, 1999. http://web4.library.adelaide.edu.au/theses/09PH/09phw878.pdf.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Mander, Ann. "Pulmonary surfactant and neutrophil function in cystic fibrosis." Thesis, University of Southampton, 1999. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.310701.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

McCarty, Kenneth Dean. "Characterization of pulmonary surfactant apoproteins in the diabetic mouse." CSUSB ScholarWorks, 1989. https://scholarworks.lib.csusb.edu/etd-project/512.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Espinosa, Frank F. (Frank Francis). "Exogenous surfactant transport through the pulmonary airways : improving surfactant replacement therapy for neonatal respiratory distress syndrome." Thesis, Massachusetts Institute of Technology, 1996. http://hdl.handle.net/1721.1/10974.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Pulmonary surfactant"

1

Rooney, Seamus A. Lung surfactant: Cellular and molecular processing. Landes Bioscience, 1998.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Kaushik, Nag, ed. Lung surfactant function and disorder. Taylor & Francis, 2005.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

1952-, Müller B., Wichert P. von, and International Symposium on Lung Surfactant (4th : 1992 : Marburg, Germany), eds. Lung surfactant: Basic research in the pathogenesis of lung disorders. Karger, 1994.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

R, Bourbon Jacques, ed. Pulmonary surfactant: Biochemical, functional, regulatory, and clinical concepts. CRC Press, 1991.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

1935-, Robertson Bengt, Golde, Lambert M. G. van, 1940-, and Batenburg J. J, eds. Pulmonary surfactant: From molecular biology to clinical practice. Elsevier, 1992.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Laboratories, Ross, ed. Surfactant treatment of lung diseases: Report of the 96th Ross Conference on Pediatric Research. Ross Laboratories, 1988.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

G, Bevilacqua, Parmigiani Stefano, and Robertson Bengt 1935-, eds. Surfactant in clinical practice: Proceedings of an international symposium, Parma, June 4-5, 1990. Harwood Academic Publishers, 1993.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Devidas, Menon, and Canadian Coordinating Office for Health Technology Assessment., eds. Exosurf Neonatal for surfactant replacement therapy. Canadian Coordinating Office for Health Technology Assessment, 1991.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

International Symposium on Surfactant Replacement Therapy (1987 Rotterdam, Netherlands). Surfactant replacement therapy in neonatal and adult respiratory distress syndrome. Springer-Verlag, 1988.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

R, Wauer R., ed. Respiratory distress syndrome of premature infants: Significance of surfactant and its pharmacological influence : pre-congress workshop of the 10th European Congress of Perinatal Medicine, Leipzig, GDR, August 12, 1986. Volk und Gesundheit, 1987.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Pulmonary surfactant"

1

Alemanno, Fernando. "Pulmonary Surfactant." In Biochemistry for Anesthesiologists and Intensivists. Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-26721-6_10.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Enhorning, G. "Evaluation of Pulmonary Surfactant." In Surfactant Replacement Therapy. Springer Berlin Heidelberg, 1988. http://dx.doi.org/10.1007/978-3-642-73305-5_2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Harwood, John L., Llinos W. Morgan, and Tanya Greatrex. "Alveolar Surfactant." In Pulmonary Biology in Health and Disease. Springer New York, 2002. http://dx.doi.org/10.1007/978-0-387-22435-0_3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Robertson, B., and S. Schürch. "Assessment of surfactant function." In Methods in Pulmonary Research. Birkhäuser Basel, 1998. http://dx.doi.org/10.1007/978-3-0348-8855-4_14.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Enhorning, G. "Pulmonary Surfactant: Evolution of Functional Concepts." In Surfactant Replacement Therapy. Springer Berlin Heidelberg, 1988. http://dx.doi.org/10.1007/978-3-642-73305-5_1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Willson, Douglas F., Patricia R. Chess, Zhengdong Wang, and Robert H. Notter. "Pulmonary Surfactant: Biology and Therapy." In The Respiratory Tract in Pediatric Critical Illness and Injury. Springer London, 2008. http://dx.doi.org/10.1007/978-1-84800-925-7_10.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Armbruster, S., J. Klein, E. M. Stouten, W. Erdmann, and B. Lachmann. "Surfactant in Pulmonary Oxygen Toxicity." In Oxygen Transport to Tissue IX. Springer US, 1987. http://dx.doi.org/10.1007/978-1-4684-7433-6_40.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Lachmann, B. "In Vivo Tests for Evaluation of Pulmonary Surfactant." In Surfactant Replacement Therapy. Springer Berlin Heidelberg, 1988. http://dx.doi.org/10.1007/978-3-642-73305-5_4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Calkovska, Andrea, and Egbert Herting. "Exogenous Surfactant in Respiratory Distress Syndrome." In Applied Technologies in Pulmonary Medicine. KARGER, 2010. http://dx.doi.org/10.1159/000322778.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Pison, Ulrich, and Sylvia Pietschmann. "Host Defense Capacities of Pulmonary Surfactant." In Acute Respiratory Distress Syndrome. Springer US, 1998. http://dx.doi.org/10.1007/978-1-4419-8634-4_11.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Pulmonary surfactant"

1

Gaver, Donald P., Melissa A. Krueger, and Samir N. Ghadiali. "The Influence of Surfactant Physicochemical Properties on Pulmonary Interfacial Flow Analogues." In ASME 1997 International Mechanical Engineering Congress and Exposition. American Society of Mechanical Engineers, 1997. http://dx.doi.org/10.1115/imece1997-0218.

Full text
Abstract:
Abstract Many of the lung’s mechanical properties are influenced by pulmonary surfactant physicochemical characteristics. Pulmonary surfactant is a complex lipid-protein mixture formed in the type II alveolar cells and secreted into the alveolar subphase [1]. These substances reduce the surface tension at the air-liquid interface of the lining fluid that coats the interior of the lung. At sufficiently high concentrations, pulmonary surfactant reduces the surface tension to near zero and. in the process, stabilizes the alveoli and small airways [2–4].
APA, Harvard, Vancouver, ISO, and other styles
2

Siebert, Trina A., and Sandra Rugonyi. "Surfactant Spreading on a Thin Film Is Sensitive to Film Thickness: Implications for In Vivo Pulmonary Systems Versus In Vitro Scenarios." In ASME 2007 Summer Bioengineering Conference. American Society of Mechanical Engineers, 2007. http://dx.doi.org/10.1115/sbc2007-174065.

Full text
Abstract:
The role of pulmonary surfactant is critical to the mechanics of the lung. Pulmonary surfactant forms a monolayer film at the air-liquid interface of a thin film of fluid lining the alveoli. Without surfactant, the air-liquid surface tension would be too high and the lungs would collapse during exhalation, as is the case with premature babies who develop respiratory distress syndrome (RDS) because they lack a sufficient amount of pulmonary surfactant [1]. Because an increase in surfactant surface concentration correlates with a decrease in surface tension, the surface tension gradients resulti
APA, Harvard, Vancouver, ISO, and other styles
3

Kolmogorov, I. M., V. A. Timoshenko, I. V. Grigoryan, and I. M. Le-Deygen. "INTERACTION OF LIPOSOMAL FORMS OF LEVOFLOXACIN WITH PULMONARY SURFACTANT." In XI МЕЖДУНАРОДНАЯ КОНФЕРЕНЦИЯ МОЛОДЫХ УЧЕНЫХ: БИОИНФОРМАТИКОВ, БИОТЕХНОЛОГОВ, БИОФИЗИКОВ, ВИРУСОЛОГОВ, МОЛЕКУЛЯРНЫХ БИОЛОГОВ И СПЕЦИАЛИСТОВ ФУНДАМЕНТАЛЬНОЙ МЕДИЦИНЫ. IPC NSU, 2024. https://doi.org/10.25205/978-5-4437-1691-6-77.

Full text
Abstract:
The interaction between liposomal levofloxacin and bovine pulmonary surfactant was investigated. It has been demonstrated using Langmuir-Wilhelmy techniques, AFM, IR and fluorescence microscopy that functionalizing the surface of liposomes with mannosylated chitosan minimizes the initial fusion of vesicles with surfactant, while also assisting in the retention of the formulation at the surfactant-air interface.
APA, Harvard, Vancouver, ISO, and other styles
4

Numata-Nakamura, M., H. Lee, H. W. Chu, M. A. Seibold, and D. R. Voelker. "Pulmonary Surfactant Lipids Antagonize Human Rhinovirus Infections." In American Thoracic Society 2019 International Conference, May 17-22, 2019 - Dallas, TX. American Thoracic Society, 2019. http://dx.doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a5757.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Meissner, Sven, Stefan Adami, Lilla Knels, Xiangyu Hu, Nikolaus Adams, and Edmund Koch. "Experimental And Numerical Studies On Pulmonary Surfactant." In American Thoracic Society 2010 International Conference, May 14-19, 2010 • New Orleans. American Thoracic Society, 2010. http://dx.doi.org/10.1164/ajrccm-conference.2010.181.1_meetingabstracts.a3021.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Briva, Arturo, Leonel Malacrida, Horacio Botti, et al. "Halogenated Anesthetics Impairs Biophysical Properties Of Pulmonary Surfactant." In American Thoracic Society 2011 International Conference, May 13-18, 2011 • Denver Colorado. American Thoracic Society, 2011. http://dx.doi.org/10.1164/ajrccm-conference.2011.183.1_meetingabstracts.a5241.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Arciniegas Flores, R. A., I. A. Vital, K. Medepalli, D. DeMarzo, M. K. Glassberg Csete, and R. A. Alvarez. "Pulmonary Fibrosis Due to a Novel Surfactant Protein Mutation." In American Thoracic Society 2019 International Conference, May 17-22, 2019 - Dallas, TX. American Thoracic Society, 2019. http://dx.doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a5437.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Suman, A., N. Sinha, H. Kaura, H. Rawal, and A. G. Espinoza. "Drowning in Surfactant - A Case of Pulmonary Alveolar Proteinosis." In American Thoracic Society 2020 International Conference, May 15-20, 2020 - Philadelphia, PA. American Thoracic Society, 2020. http://dx.doi.org/10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a1478.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Hall, Stephen B., Ryan W. Loney, and Shankar B. Rananavare. "Mechanisms Of The Late Accelerated Adsorption Of Pulmonary Surfactant." In American Thoracic Society 2011 International Conference, May 13-18, 2011 • Denver Colorado. American Thoracic Society, 2011. http://dx.doi.org/10.1164/ajrccm-conference.2011.183.1_meetingabstracts.a5243.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Furuhashi, K., S. Sakurai, H. Yasui, et al. "Surfactant Protein D in Patients with Chronic Pulmonary Aspergillosis." In American Thoracic Society 2019 International Conference, May 17-22, 2019 - Dallas, TX. American Thoracic Society, 2019. http://dx.doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a3694.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Pulmonary surfactant"

1

Cochrane, Charles G. Clinical Studies of Synthetic Peptide-Containing Pulmonary Surfactant in Patients with Adult Respiratory Distress Syndrome. Defense Technical Information Center, 1995. http://dx.doi.org/10.21236/ada302217.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Rodríguez, Antonio Cruz, Begoña García Álvarez, and Bárbara Olmeda Lozano. El surfactante pulmonar, un sistema lipoproteico clave para la mecánica respiratoria. Sociedad Española de Bioquímica y Biología Molecular, 2023. http://dx.doi.org/10.18567/sebbmrev_215.202303.dc004.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Pulmonary surfactant' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography